Hepatitis C, Chronic, HIV Infection
Conditions
Keywords
Hepatitis C, Chronic, HIV Infection, Medication Adherence, Questionnaire Design, Treatment experienced
Brief summary
Main objective: To study and validate a questionnaire measuring treatment adherence in patients with Hepatitis C virus (HCV) infection. Design of the study: Multicentric, prospective, epidemiological study in the field of usual clinical practice.
Interventions
Adherence questionnaire
Sponsors
Study design
Eligibility
Inclusion criteria
* Ambulatory patient infected by HCV according to diagnosis criteria used en usual clinical practice. * Patient no treated previously and beginning a treatment for HCV. * Patient that signed the informed consent to participate in the study. * Group A: patient with HCV monoinfection. * Group B: patient with HCV and HCV co-infection (according to diagnosis criteria used en usual clinical practice).
Exclusion criteria
* Patient that received previous treatment for HCV. * Patient that is going to participate in a clinical trial Turing the HCV treatment period. * Patient with cognitive impairment or patient unable to understand and answer the auto-administered questionnaire. * Patient unable to read or write Spanish.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Main objective of the study is the development and validation of a Questionnaire measuring treatment adherence in patients with HCV infection. | 2 years |
Secondary
| Measure | Time frame |
|---|---|
| Adherence will be measured according to 80/80/80 rule. | 2 years |
| Establish a relationship between adherence, virological response (VR) and Sustained virological response (SVR). | 2 years |
Countries
Spain